[1] Li XJ, Ren Y, Tian HM, et al. True insulin and proinsulin profile in normal glucose tolerant first Ren Y, Tian HM, et al.Elevated serum ferritin concentrations in a glucose-impaired population and in normal glucose tolera.DIABETES CARE, 2004,27(2)
[2] Chen X，Tian HM, et al.Association of serum apolipoprotein C III levels and apolipoprotein C III gene Sst I polymorphism wi.DIABETES RESEARCH AND CLINICAL PRACTICE, 2004,66(1)
[3] Hu YM, Tian HM, Liu R, et al.Gln-Arg192 polymorphism of paraoxonase 1 is associated with carotid intima-media thickness in patients of type 2 diabetes mellitus of Chinese..Diabetes Res Clin Pract, 2003,61(1)
[4] Chen X, Tian HM, Liu R, et al.Association between fasting and postprandial triglyceride levels and carotid intima-media thickness .CHINESE MED J, 2003,116(12)
[5] Tian HM, Han LC, Ren Yan et al. Lipoprotein(a) level and lipids in type 2 diabetic patients and their normoglycemic first-degree relatives in type 2 diabetic pedigrees.Diabetes Res Clin Pract, 2003,59(1)
[6] degree relatives in familial type 2 diabetic pedigrees. Diabetologia 2002,45(suppl 2):A32, 90.
[7] Shu J, Tian HM, Liu Rui, et al.Inhibitive effects of glucose and free fatty acids on proliferation of human vascular www.med126.com endothelial cells in vitro.Chinese Medical Journal, 2002,115(10)
[8] Hu YM, Tian HM, Liu R, et al.Difference in DNA sequences in SSU rDNA variable regions among pathogens isolated from different epidemic foci of visceral leishmaniasis in China.DIABETOLOGIA, 2002,45()
[9] Ren Y，Li XJ , Tian HM, el al. Molecular scanning of candidate mtDNA geng fragment in maternal diabetic pedigrees. Diabetes 2002,51(supplement2),A 616,2558.
[10] Ren Y，Tian HM ，Liu BW，et al .Abnormal changes of apolipoproteins in type2 diabetes mellitus associated with dyslipidemia and cornary heart disease ,The Endocrine Society (Program and abstracts)82nd Annual Meeting 2000,435,1795
[11] Ren Y，Tian HM，Liu R，et al. Apolipoprotein CIII gene SstI polymorphsim in patients of type 2 diabetes associated with hypertriglyceridemia in a Chinese population. The Endocrine Society (Program and abstracts 82nd Annual Meeting 2000;435,1805.
[12] 李建薇,田浩明,喻红霖,张祥迅,赵桂枝.那格列奈与瑞格列奈治疗2型糖尿病的随机双盲对照研究.四川大学学报（医学版), 2005,36(2)
[13] 赵月萍,田浩明.新诊断2型糖尿病短期胰岛素强化治疗.四川医学, 2005,26(2)
[14] 刘玉平,田浩明.库欣综合征与糖代谢紊乱.四川医学, 2005,26(2)
[15] 李亚,田浩明.2型糖尿病胆囊结石与游离脂肪酸及胰岛素抵抗的相关性分析.四川医学, 2005,26(2)
[16] 王晓辉,田浩明.2型糖尿病患者血浆皮质醇www.med126.com、游离脂肪酸水平和胰岛素抵抗.中华内分泌代谢杂志, 2004,20(3)
[17] 曹旭,田浩明.腹部肥胖导致胰岛素抵抗和2型糖尿病的分子机制.华西医学, 2004,19(2)
[18] 陈德才,田浩明.骨质疏松症的药物治疗循证.华西医学, 2004,19(1)
[19] 田浩明,魏东,贾海燕.葛根素治疗糖尿病周围神经病变的系统评价.中国循证医学杂志, 2004,4(8)
[20] 田浩明,李启富,王乃尊,吴桐,刘雅.国产那格列奈与瑞格列奈治疗2型糖尿病的多中心随机对照双盲双模拟临床试验.中国循证医学杂志, 2004,4(7)
[21] 胡耀敏,田浩明,刘瑞,陈香.血浆致动脉硬化指数与2型糖尿病患者颈动脉内膜中层厚度的相关性研究.四川大学学报（医学版), 2004,35(5)
[22] 韩令川,田浩明,任艳,李秀钧,王嘉南.中国人2型糖尿病家系中糖尿病患者及其一级亲属血脂和载脂蛋白的研究.中华内分泌代谢杂志, 2004,19(6)
[23] 田浩明,李秀钧.2型糖尿病的病因遗传学研究进展.国外医学·内分泌学分册, 2002,22(2)
[24] 田浩明.循证医学在糖尿病研究和治疗中的应用.四川医学, 2002,23(9)
[25] 田浩明,王玉华,任艳.治疗中的2型糖尿病患者空腹及三餐后4小时甘油三酯水平的观察.华西医科大学学报, 2002,33(4)
[26] 田浩明,李明初,梁荩忠.Reiter综合征1例报告.中国全科医学, 2001,4(9)
[27] 田浩明,李明初,梁荩忠.谷氨酸脱羧酶抗体测定对不易分型成人糖尿病的临床意义.华西医科大学学报, 2001,32(1)
[28] 田浩明,苏进.游离脂肪酸与肥胖和糖尿病.辽宁实用糖尿病杂志, 2000,2(2)
联系方式:
电话： 028-8542257 　　　邮箱:hmtian999@yahoo.com.cn

上一页  [1] [2] [3]  下一页